Chungyeul Kim
Chungyeul Kim
Verified email at
Cited by
Cited by
A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer
S Paik, S Shak, G Tang, C Kim, J Baker, M Cronin, FL Baehner, ...
New England Journal of Medicine 351 (27), 2817-2826, 2004
Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor–positive breast cancer
S Paik, G Tang, S Shak, C Kim, J Baker, W Kim, M Cronin, FL Baehner, ...
Journal of clinical oncology 24 (23), 3726-3734, 2006
HER2 Status and Benefit from Adjuvant Trastuzumab in Breast Cancer
S Paik, C Kim, N Wolmark
New England Journal of Medicine 358 (13), 1409-1411, 2008
Mutation profiling and microsatellite instability in stage II and III colon cancer: an assessment of their prognostic and oxaliplatin predictive value
PG Gavin, LH Colangelo, D Fumagalli, N Tanaka, MY Remillard, ...
Clinical cancer research 18 (23), 6531-6541, 2012
Gene-expression-based prognostic assays for breast cancer
C Kim, S Paik
Nature reviews Clinical oncology 7 (6), 340-347, 2010
Estrogen receptor (ESR1) mRNA expression and benefit from tamoxifen in the treatment and prevention of estrogen receptor–positive breast cancer
C Kim, G Tang, KL Pogue-Geile, JP Costantino, FL Baehner, J Baker, ...
Journal of clinical oncology 29 (31), 4160, 2011
Multi-gene RT-PCR assay for predicting recurrence in node negative breast cancer patients-NSABP studies B-20 and B-14
S Paik, S Shak, G Tang, C Kim, J Baker, M Cronin, R Baehner, M Walker, ...
Breast Cancer Research and Treatment 82, S10-S11, 2003
Predicting degree of benefit from adjuvant trastuzumab in NSABP trial B-31
KL Pogue-Geile, C Kim, JH Jeong, N Tanaka, H Bandos, PG Gavin, ...
Journal of the National Cancer Institute 105 (23), 1782-1788, 2013
Evaluation of microtubule-associated protein-Tau expression as a prognostic and predictive marker in the NSABP-B 28 randomized clinical trial
L Pusztai, JH Jeong, Y Gong, JS Ross, C Kim, S Paik, R Rouzier, F Andre, ...
Journal of clinical oncology 27 (26), 4287, 2009
Technology insight: Application of molecular techniques to formalin-fixed paraffin-embedded tissues from breast cancer
S Paik, C Kim, Y Song, W Kim
Nature Clinical Practice Oncology 2 (5), 246-254, 2005
Expression of the 21 genes in the Recurrence Score assay and tamoxifen clinical benefit in the NSABP study B-14 of node negative, estrogen receptor positive breast cancer
S Paik, S Shak, G Tang, C Kim, J Baker, M Cronin, D Watson, J Bryant, ...
Journal of Clinical Oncology 23 (16_suppl), 510-510, 2005
Immunohistochemistry and fluorescence in situ hybridization assessment of HER2 in clinical trials of adjuvant therapy for breast cancer (NCCTG N9831, BCIRG 006, and BCIRG 005)
EA Perez, MF Press, AC Dueck, RB Jenkins, C Kim, B Chen, I Villalobos, ...
Breast Cancer Research and Treatment 138, 99-108, 2013
Benefit from adjuvant trastuzumab may not be confined to patients with IHC 3+ and/or FISH-positive tumors: Central testing results from NSABP B-31
S Paik, C Kim, J Jeong, CE Geyer, EH Romond, O Mejia-Mejia, ...
Journal of Clinical Oncology 25 (18_suppl), 511-511, 2007
Trastuzumab sensitivity of breast cancer with co-amplification of HER2 and cMYC suggests pro-apoptotic function of dysregulated cMYC in vivo.
C Kim, J Bryant, Z Horne, CE Geyer, DL Wickerham, N Wolmark, S Paik
Breast cancer research and treatment 94, S6-S7, 2005
Expression of the 21 genes in the Recurrence Score assay and prediction of clinical benefit from tamoxifen in NSABP study B-14 and chemotherapy in NSABP study B-20
S Paik, S Shak, G Tang, C Kim, H Joo, J Baker, M Cronin, D Watson, ...
Breast Cancer Research and Treatment 88, S15-S15, 2004
Methods of whole genome or microarray expression profiling using nucleic acids prepared from formalin fixed paraffin embedded tissue
S Paik, K Pogue-Geile, C Kim
US Patent App. 11/796,752, 2007
Akt phosphorylation at Ser473 predicts benefit of paclitaxel chemotherapy in node-positive breast cancer
SX Yang, JP Costantino, C Kim, EP Mamounas, D Nguyen, JH Jeong, ...
Journal of Clinical Oncology 28 (18), 2974, 2010
Chemosensitivity and stratification by a five monoclonal antibody immunohistochemistry test in the NSABP B14 and B20 trials
DT Ross, C Kim, G Tang, OL Bohn, RA Beck, BZ Ring, RS Seitz, S Paik, ...
Clinical cancer research 14 (20), 6602-6609, 2008
Biomarker discovery for colon cancer using a 761 gene RT-PCR assay
KM Clark-Langone, JY Wu, C Sangli, A Chen, JL Snable, A Nguyen, ...
BMC genomics 8 (1), 1-18, 2007
Anticancer effect of metformin on estrogen receptor-positive and tamoxifen-resistant breast cancer cell lines
J Kim, J Lee, SY Jang, C Kim, Y Choi, A Kim
Oncology reports 35 (5), 2553-2560, 2016
The system can't perform the operation now. Try again later.
Articles 1–20